Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients

NCT02545595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Morbid Obesity

Interventions

DRUG: Sugammadex 1 mg/kg
DRUG: Sugammadex 2 mg/kg
DRUG: Sugammadex 4 mg/kg

Sponsor

Poitiers University Hospital